| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Prochlorperazine maleate |
Is a |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine edisylate |
Is a |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Compazine measurement |
Component |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Poisoning by prochlorperazine |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental prochlorperazine poisoning |
Causative agent (attribute) |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Intentional prochlorperazine poisoning |
Causative agent (attribute) |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| intoxication par la prochlorpérazine d'intention indéterminée |
Causative agent (attribute) |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine overdose |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental prochlorperazine overdose |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
2 |
| Intentional prochlorperazine overdose (disorder) |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
2 |
| surdose de prochlorpérazine d'intention indéterminée |
Causative agent (attribute) |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine [antipsych] [see dhe..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine [nausea] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Product containing prochlorperazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine 2.5 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine 25mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Oral form prochlorperazine m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine mesilate |
Is a |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Product containing prochlorperazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine edisylate 5mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine edisylate 5mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine edisylate 5mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine maleate 25 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Intentional prochlorperazine poisoning |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine adverse reaction |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to prochlorperazine (finding) |
Causative agent (attribute) |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Accidental poisoning caused by prochlorperazine (disorder) |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to prochlorperazine (finding) |
Causative agent (attribute) |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine measurement (procedure) |
Component |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 10 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 15 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine mesilate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine maleate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine edisylate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
|
| Prochlorperazine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 10 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 15 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prochlorperazine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prochlorperazine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 2.5 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 2.5 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
| Prochlorperazine 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prochlorperazine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]